ZA201807736B - Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursors - Google Patents
Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursorsInfo
- Publication number
- ZA201807736B ZA201807736B ZA2018/07736A ZA201807736A ZA201807736B ZA 201807736 B ZA201807736 B ZA 201807736B ZA 2018/07736 A ZA2018/07736 A ZA 2018/07736A ZA 201807736 A ZA201807736 A ZA 201807736A ZA 201807736 B ZA201807736 B ZA 201807736B
- Authority
- ZA
- South Africa
- Prior art keywords
- derivatives
- ribosite
- nad
- nicotinamide
- precursors
- Prior art date
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title 2
- PUEDDPCUCPRQNY-ZYUZMQFOSA-N D-ribosylnicotinate Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1[N+]1=CC=CC(C([O-])=O)=C1 PUEDDPCUCPRQNY-ZYUZMQFOSA-N 0.000 title 1
- 235000005152 nicotinamide Nutrition 0.000 title 1
- 239000011570 nicotinamide Substances 0.000 title 1
- 229960003966 nicotinamide Drugs 0.000 title 1
- 239000002243 precursor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662325264P | 2016-04-20 | 2016-04-20 | |
| PCT/US2017/028673 WO2017184885A1 (en) | 2016-04-20 | 2017-04-20 | Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201807736B true ZA201807736B (en) | 2020-05-27 |
Family
ID=60088650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2018/07736A ZA201807736B (en) | 2016-04-20 | 2018-11-16 | Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10183036B2 (enExample) |
| EP (1) | EP3445359B8 (enExample) |
| JP (3) | JP7089480B2 (enExample) |
| KR (1) | KR20190008246A (enExample) |
| CN (1) | CN109640984A (enExample) |
| AU (2) | AU2017254657A1 (enExample) |
| BR (1) | BR112018071573A2 (enExample) |
| CA (1) | CA3021571C (enExample) |
| ES (1) | ES2948968T3 (enExample) |
| MX (1) | MX393076B (enExample) |
| NZ (1) | NZ747693A (enExample) |
| WO (1) | WO2017184885A1 (enExample) |
| ZA (1) | ZA201807736B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10392414B2 (en) | 2015-07-15 | 2019-08-27 | Cornell University | Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives |
| AU2016302005B2 (en) | 2015-08-05 | 2021-03-04 | Metro International Biotech, Llc | Nicotinamide mononucleotide derivatives and their uses |
| GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
| EP3538099A4 (en) | 2016-11-11 | 2020-06-17 | The Queen's University of Belfast | EFFICIENT AND SCALABLE SYNTHESIS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS OF THEM, ADENYLYDINUCLEOTIDE CONJUGATES THEREOF AND NEW-WAY CRYSTALS |
| EP3554285A4 (en) | 2016-11-29 | 2021-01-20 | University of Iowa Research Foundation | USE OF NAD PRECURSORS TO IMPROVE THE HEALTH OF MOTHER AND / OR OFFspring |
| US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
| WO2018191771A1 (en) * | 2017-04-18 | 2018-10-25 | Victor Chang Cardiac Research Institute | Detection and treatment of congenital malformations |
| EP3642214A2 (en) | 2017-06-19 | 2020-04-29 | Gangadhara Ganapati | Nicotinamide riboside derivatives and their uses |
| WO2019152416A1 (en) * | 2018-01-30 | 2019-08-08 | Metro International Biotech, Llc | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof |
| CN113490675B (zh) * | 2018-05-22 | 2026-01-09 | 江普斯塔特生育有限公司 | 作为抗衰老剂的烟酸核苷的氨基酸盐 |
| US11833167B2 (en) | 2018-12-17 | 2023-12-05 | Mitopower Llc | Nicotinyl riboside compounds and their uses |
| EP3927715A4 (en) * | 2019-02-21 | 2023-03-01 | Chromadex, Inc. | Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations |
| US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
| JP2022534872A (ja) * | 2019-06-05 | 2022-08-04 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 肝疾患の治療のための還元型ニコチンアミドリボシド |
| AU2020286602B2 (en) * | 2019-06-05 | 2025-04-03 | Société des Produits Nestlé S.A. | Reduced nicotinamideribosides for treating or preventing kidney disease |
| BR112021021690A2 (pt) * | 2019-06-05 | 2022-02-15 | Nestle Sa | Ribosídeos de nicotinamida reduzidos para tratamento/prevenção de doenças do músculo esquelético |
| CN110973260A (zh) * | 2019-12-11 | 2020-04-10 | 杨力 | 一种含有烟酰胺核糖苷的牛奶及其制备方法与应用 |
| EP4076458A1 (en) | 2019-12-19 | 2022-10-26 | Leibniz-lnstitut Für Altersforschung | Nad-precursors and dietary restriction for treating age-related medical conditions |
| EP4117681A1 (en) * | 2020-03-09 | 2023-01-18 | Société des Produits Nestlé S.A. | Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of pancreatic diseases and conditions |
| WO2021180731A1 (en) * | 2020-03-09 | 2021-09-16 | Société des Produits Nestlé S.A. | Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of cardiovascular diseases and conditions |
| US20230114280A1 (en) * | 2020-03-09 | 2023-04-13 | Societe Des Produits Nestle S.A. | Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of neurological diseases and conditions |
| EP4117680A1 (en) * | 2020-03-09 | 2023-01-18 | Société des Produits Nestlé S.A. | Compositions and methods containing reduced nicotinamide riboside for prevention and treatment of lung diseases and conditions |
| CN114561342B (zh) * | 2020-11-27 | 2024-12-20 | 西安交通大学医学院第一附属医院 | Nad信号通路激动剂在体外胚胎培养中的应用 |
| CN112716969B (zh) * | 2021-01-15 | 2022-11-29 | 江苏恒正合生命科学有限公司 | 治疗阿尔茨海默症的组合物及其制备方法、应用 |
| CN118201621A (zh) * | 2021-05-05 | 2024-06-14 | 雀巢产品有限公司 | 使用narh和nr的组合来产生细胞内烟酰胺腺嘌呤二核苷酸（nad+）的组合物和方法 |
| IL308577A (en) | 2021-05-27 | 2024-01-01 | Metro Int Biotech Llc | Crystalline solids of nicotinic acid mononucleotides and their esters and methods for their preparation and use |
| CA3224544A1 (en) * | 2021-06-18 | 2022-12-22 | Mitopower Llc | Treatment of immune-related disorders, kidney disorders, liver disorders, hemolytic disorders, and oxidative stress-associated disorders using nrh, narh and reduced derivatives thereof |
| JP7111878B1 (ja) | 2021-10-27 | 2022-08-02 | 旭化成ファーマ株式会社 | ニコチンアミドモノヌクレオチドの製造方法 |
| EP4422644A4 (en) * | 2021-10-27 | 2025-08-27 | Elysium Health Inc | METHODS OF TREATING MENOPAUSAL SYNDROMES |
| WO2023150072A1 (en) | 2022-02-01 | 2023-08-10 | Sinclair David A | Compositions and methods for the preservation of plant matter |
| EP4472993A2 (en) * | 2022-02-04 | 2024-12-11 | Elysium Health, Inc. | Ribose linkers and conjugates thereof |
| WO2024118503A1 (en) | 2022-11-28 | 2024-06-06 | Hongene Biotech Corporation | Functionalized n-acetylgalactosamine analogs |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022680B2 (en) * | 2002-05-30 | 2006-04-04 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases |
| US7977049B2 (en) | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| US7927859B2 (en) * | 2003-08-22 | 2011-04-19 | Rice University | High molar succinate yield bacteria by increasing the intracellular NADH availability |
| WO2005077091A2 (en) | 2004-02-10 | 2005-08-25 | Trustees Of Dartmouth College | Nicotinamide riboside kinase compositions and methods for using the same |
| PT1755391E (pt) | 2004-06-04 | 2016-02-03 | Univ Washington | Métodos e composições para o tratamento de neuropatias |
| ES2670927T3 (es) * | 2005-11-18 | 2018-06-04 | Cornell Research Foundation, Inc. | Composiciones de nicotinoil ribósido y métodos de uso |
| GB201313465D0 (en) | 2013-07-29 | 2013-09-11 | Queens University Of The Belfast | Methods of preparing nicotinamide riboside and derivatives thereof |
| KR20210107895A (ko) | 2013-10-30 | 2021-09-01 | 크로마덱스 아이엔씨. | 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 |
| RU2016149767A (ru) | 2014-06-06 | 2018-07-16 | Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед | Аналоги никотинамидрибозида и фармацевтические композиции и их применение |
| BR112017019696A2 (pt) * | 2015-03-16 | 2018-09-04 | ChromaDex Inc. | composto e usos de um composto |
| US10392414B2 (en) | 2015-07-15 | 2019-08-27 | Cornell University | Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives |
| AU2016302005B2 (en) | 2015-08-05 | 2021-03-04 | Metro International Biotech, Llc | Nicotinamide mononucleotide derivatives and their uses |
| ES2981479T3 (es) * | 2016-04-14 | 2024-10-09 | Chromadex Inc | Fórmula para lactantes que comprende ribósido de nicotinamida |
-
2017
- 2017-04-20 MX MX2018012849A patent/MX393076B/es unknown
- 2017-04-20 AU AU2017254657A patent/AU2017254657A1/en not_active Abandoned
- 2017-04-20 EP EP17786649.8A patent/EP3445359B8/en active Active
- 2017-04-20 US US15/492,952 patent/US10183036B2/en active Active
- 2017-04-20 ES ES17786649T patent/ES2948968T3/es active Active
- 2017-04-20 BR BR112018071573-5A patent/BR112018071573A2/pt not_active Application Discontinuation
- 2017-04-20 CA CA3021571A patent/CA3021571C/en active Active
- 2017-04-20 KR KR1020187033413A patent/KR20190008246A/ko not_active Ceased
- 2017-04-20 NZ NZ747693A patent/NZ747693A/en unknown
- 2017-04-20 JP JP2018554765A patent/JP7089480B2/ja active Active
- 2017-04-20 CN CN201780038245.5A patent/CN109640984A/zh active Pending
- 2017-04-20 WO PCT/US2017/028673 patent/WO2017184885A1/en not_active Ceased
-
2018
- 2018-11-16 ZA ZA2018/07736A patent/ZA201807736B/en unknown
-
2021
- 2021-07-16 JP JP2021117648A patent/JP2021176871A/ja active Pending
-
2022
- 2022-08-22 AU AU2022221384A patent/AU2022221384C1/en active Active
- 2022-10-19 JP JP2022167877A patent/JP7493007B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7089480B2 (ja) | 2022-06-22 |
| CA3021571C (en) | 2023-01-03 |
| BR112018071573A2 (pt) | 2019-02-12 |
| AU2022221384B2 (en) | 2023-03-23 |
| JP2019514874A (ja) | 2019-06-06 |
| AU2022221384C1 (en) | 2023-08-03 |
| EP3445359C0 (en) | 2023-06-07 |
| NZ747693A (en) | 2023-07-28 |
| WO2017184885A1 (en) | 2017-10-26 |
| US20170304338A1 (en) | 2017-10-26 |
| EP3445359B8 (en) | 2023-09-06 |
| MX2018012849A (es) | 2019-08-29 |
| US10183036B2 (en) | 2019-01-22 |
| EP3445359A4 (en) | 2019-12-25 |
| JP2021176871A (ja) | 2021-11-11 |
| CN109640984A (zh) | 2019-04-16 |
| CA3021571A1 (en) | 2017-10-26 |
| KR20190008246A (ko) | 2019-01-23 |
| EP3445359B1 (en) | 2023-06-07 |
| AU2017254657A1 (en) | 2018-11-15 |
| ES2948968T3 (es) | 2023-09-22 |
| JP7493007B2 (ja) | 2024-05-30 |
| AU2022221384A1 (en) | 2022-09-22 |
| JP2023002685A (ja) | 2023-01-10 |
| MX393076B (es) | 2025-03-24 |
| WO2017184885A8 (en) | 2023-08-24 |
| EP3445359A1 (en) | 2019-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201807736B (en) | Use of nicotinic acid riboside or nicotinamide ribosite derivatives, and reduced derivatives thereof, as nad+increasing precursors | |
| ZA201706918B (en) | Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof | |
| ZA201807586B (en) | Use of nicotinamide riboside, nicotinic acid riboside, nicotinamide mononucleotide, and nicotinoyl compound derivatives in infant formula | |
| SG11201912267SA (en) | Nicotinamide riboside derivatives and their uses | |
| ZA201705776B (en) | Crystalline form of nicotinamide riboside | |
| IL244276B (en) | Pyrimidinone, pyridizinone, pyridinone or triazinone derivatives, pharmaceutical preparations including them and their use | |
| EP3174891A4 (en) | Crystalline form of nicotinamide riboside | |
| EP3322419A4 (en) | Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives | |
| ZA201506484B (en) | 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors | |
| EP3094175A4 (en) | Herbicidal composition containing 4-amino-3-choro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2- carboxylic acid, fluroxypyr and phenoxyauxins | |
| SMT201900605T1 (it) | Derivati di pirimidina utili come inibitori delettivi di jak3 e/o jak1 | |
| GB201614214D0 (en) | Lactone intermediates of nicotinamide riboside and nicotinate riboside | |
| IL267042B (en) | New picolinic acid histories and their use as intermediates | |
| GB2555748B (en) | Novel form of isoxadifen-ethyl, process for preparation and use thereof | |
| IL263652A (en) | History of bicyclic pyridine, pyrazine, and pyrimidine as PI3K inhibitors in the cell | |
| EP3275882A4 (en) | Process of synthesizing substituted pyridine and pyrimidine compound | |
| EP3253202A4 (en) | Acid herbicide-containing compositions, precursors, derivatives, and methods | |
| EP3255150A4 (en) | Microorganism capable of producing quinolinic acid, and method for producing quinolinic acid utilizing the microorganism | |
| HK40015980A (en) | Polymorphs of sepiapterin and salts thereof | |
| GB201710316D0 (en) | Dietary composition of nicotinamide riboside, choline and succinic acid or salts thereof | |
| HK40008417A (en) | New picolinic acid derivatives and their use as intermediates | |
| GB201615010D0 (en) | Delayed-gelling, inhibited starches and methods of using them | |
| GB201510967D0 (en) | Fluorogenic amino acid derivatives, process of preparation thereof and methods of use | |
| GB201514761D0 (en) | Preparation and uses of pyrimidinone derivatives |